CN115466758A - Method for producing D-psicose by fermenting escherichia coli with methanol and D-xylose - Google Patents
Method for producing D-psicose by fermenting escherichia coli with methanol and D-xylose Download PDFInfo
- Publication number
- CN115466758A CN115466758A CN202211129170.0A CN202211129170A CN115466758A CN 115466758 A CN115466758 A CN 115466758A CN 202211129170 A CN202211129170 A CN 202211129170A CN 115466758 A CN115466758 A CN 115466758A
- Authority
- CN
- China
- Prior art keywords
- alse
- psicose
- gene
- coli
- methanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 title claims abstract description 119
- BJHIKXHVCXFQLS-PUFIMZNGSA-N D-psicose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C(=O)CO BJHIKXHVCXFQLS-PUFIMZNGSA-N 0.000 title claims abstract description 44
- 241000588724 Escherichia coli Species 0.000 title claims abstract description 36
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 title claims abstract description 24
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 title claims abstract description 24
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 14
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 68
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 30
- 241000252067 Megalops atlanticus Species 0.000 claims abstract description 27
- 238000000855 fermentation Methods 0.000 claims abstract description 23
- 230000004151 fermentation Effects 0.000 claims abstract description 22
- 230000037361 pathway Effects 0.000 claims abstract description 8
- 229910019142 PO4 Inorganic materials 0.000 claims abstract description 7
- 239000006227 byproduct Substances 0.000 claims abstract description 7
- 239000010452 phosphate Substances 0.000 claims abstract description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 6
- 238000003786 synthesis reaction Methods 0.000 claims abstract description 6
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 4
- 230000002414 glycolytic effect Effects 0.000 claims abstract description 4
- -1 pentose phosphate Chemical class 0.000 claims abstract description 4
- 238000000034 method Methods 0.000 claims description 17
- 108090000790 Enzymes Proteins 0.000 claims description 14
- 102000004190 Enzymes Human genes 0.000 claims description 14
- 230000000694 effects Effects 0.000 claims description 13
- 238000006243 chemical reaction Methods 0.000 claims description 11
- 101100519658 Mus musculus Pfkm gene Proteins 0.000 claims description 8
- 238000006555 catalytic reaction Methods 0.000 claims description 8
- 239000000243 solution Substances 0.000 claims description 7
- 101100269719 Escherichia coli (strain K12) alsE gene Proteins 0.000 claims description 6
- 101100463616 Mus musculus Pfkl gene Proteins 0.000 claims description 5
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 claims description 4
- 239000007995 HEPES buffer Substances 0.000 claims description 4
- 238000002474 experimental method Methods 0.000 claims description 4
- 238000003209 gene knockout Methods 0.000 claims description 4
- 238000004128 high performance liquid chromatography Methods 0.000 claims description 4
- 230000002194 synthesizing effect Effects 0.000 claims description 4
- 241001465677 Ancylostomatoidea Species 0.000 claims description 3
- 241000894006 Bacteria Species 0.000 claims description 3
- 101100190555 Dictyostelium discoideum pkgB gene Proteins 0.000 claims description 3
- 101100453320 Pyrococcus furiosus (strain ATCC 43587 / DSM 3638 / JCM 8422 / Vc1) pfkC gene Proteins 0.000 claims description 3
- 101100029403 Synechocystis sp. (strain PCC 6803 / Kazusa) pfkA2 gene Proteins 0.000 claims description 3
- 230000006801 homologous recombination Effects 0.000 claims description 3
- 238000002744 homologous recombination Methods 0.000 claims description 3
- 101150038284 pfkA gene Proteins 0.000 claims description 3
- 101150004013 pfkA1 gene Proteins 0.000 claims description 3
- 101150060387 pfp gene Proteins 0.000 claims description 3
- 101150003316 rpiA gene Proteins 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 241000193398 Bacillus methanolicus Species 0.000 claims description 2
- 241000606124 Bacteroides fragilis Species 0.000 claims description 2
- GSXOAOHZAIYLCY-UHFFFAOYSA-N D-F6P Natural products OCC(=O)C(O)C(O)C(O)COP(O)(O)=O GSXOAOHZAIYLCY-UHFFFAOYSA-N 0.000 claims description 2
- 241000589346 Methylococcus capsulatus Species 0.000 claims description 2
- BGWGXPAPYGQALX-ARQDHWQXSA-N beta-D-fructofuranose 6-phosphate Chemical compound OC[C@@]1(O)O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O BGWGXPAPYGQALX-ARQDHWQXSA-N 0.000 claims description 2
- 230000004927 fusion Effects 0.000 claims description 2
- 101150100557 pfkB gene Proteins 0.000 claims description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 claims description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims 2
- 241001646716 Escherichia coli K-12 Species 0.000 claims 1
- 230000003834 intracellular effect Effects 0.000 claims 1
- 229910001629 magnesium chloride Inorganic materials 0.000 claims 1
- 238000000527 sonication Methods 0.000 claims 1
- GSXOAOHZAIYLCY-NGJCXOISSA-N D-psicose 6-phosphate Chemical compound OCC(=O)[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O GSXOAOHZAIYLCY-NGJCXOISSA-N 0.000 abstract description 6
- 102000004195 Isomerases Human genes 0.000 abstract description 3
- 108090000769 Isomerases Proteins 0.000 abstract description 3
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 abstract description 3
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 abstract description 3
- 108010048916 alcohol dehydrogenase (acceptor) Proteins 0.000 abstract description 2
- 241000588914 Enterobacter Species 0.000 abstract 1
- 239000000047 product Substances 0.000 description 15
- 108020001507 fusion proteins Proteins 0.000 description 5
- 102000037865 fusion proteins Human genes 0.000 description 5
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 5
- 238000012795 verification Methods 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 229960005091 chloramphenicol Drugs 0.000 description 3
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 3
- 238000010200 validation analysis Methods 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000030609 dephosphorylation Effects 0.000 description 2
- 238000006209 dephosphorylation reaction Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000034659 glycolysis Effects 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 229930027917 kanamycin Natural products 0.000 description 2
- 229960000318 kanamycin Drugs 0.000 description 2
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
- 229930182823 kanamycin A Natural products 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000003642 reactive oxygen metabolite Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 238000001308 synthesis method Methods 0.000 description 2
- 229910021642 ultra pure water Inorganic materials 0.000 description 2
- 239000012498 ultrapure water Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- PKAUICCNAWQPAU-UHFFFAOYSA-N 2-(4-chloro-2-methylphenoxy)acetic acid;n-methylmethanamine Chemical compound CNC.CC1=CC(Cl)=CC=C1OCC(O)=O PKAUICCNAWQPAU-UHFFFAOYSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 101100279440 Caenorhabditis elegans egg-4 gene Proteins 0.000 description 1
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 1
- LKDRXBCSQODPBY-JDJSBBGDSA-N D-allulose Chemical compound OCC1(O)OC[C@@H](O)[C@@H](O)[C@H]1O LKDRXBCSQODPBY-JDJSBBGDSA-N 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 238000003584 Ferrier rearrangement reaction Methods 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000012445 acidic reagent Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000007259 addition reaction Methods 0.000 description 1
- 238000005882 aldol condensation reaction Methods 0.000 description 1
- 239000011609 ammonium molybdate Substances 0.000 description 1
- APUPEJJSWDHEBO-UHFFFAOYSA-P ammonium molybdate Chemical compound [NH4+].[NH4+].[O-][Mo]([O-])(=O)=O APUPEJJSWDHEBO-UHFFFAOYSA-P 0.000 description 1
- 229940010552 ammonium molybdate Drugs 0.000 description 1
- 235000018660 ammonium molybdate Nutrition 0.000 description 1
- 229940057499 anhydrous zinc acetate Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 101150044508 key gene Proteins 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 238000012269 metabolic engineering Methods 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- MEFBJEMVZONFCJ-UHFFFAOYSA-N molybdate Chemical compound [O-][Mo]([O-])(=O)=O MEFBJEMVZONFCJ-UHFFFAOYSA-N 0.000 description 1
- VLAPMBHFAWRUQP-UHFFFAOYSA-L molybdic acid Chemical compound O[Mo](O)(=O)=O VLAPMBHFAWRUQP-UHFFFAOYSA-L 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- DJWUNCQRNNEAKC-UHFFFAOYSA-L zinc acetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O DJWUNCQRNNEAKC-UHFFFAOYSA-L 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/02—Monosaccharides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/90—Isomerases (5.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
- C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
- C12Y101/01244—Methanol dehydrogenase (1.1.1.244)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
- C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
- C12Y101/01284—S-(hydroxymethyl)glutathione dehydrogenase (1.1.1.284), i.e. nitroreductase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/01—Phosphotransferases with an alcohol group as acceptor (2.7.1)
- C12Y207/01011—6-Phosphofructokinase (2.7.1.11)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/02—Thioester hydrolases (3.1.2)
- C12Y301/02012—S-Formylglutathione hydrolase (3.1.2.12)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y401/00—Carbon-carbon lyases (4.1)
- C12Y401/02—Aldehyde-lyases (4.1.2)
- C12Y401/02043—3-Hexulose-6-phosphate synthase (4.1.2.43)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y503/00—Intramolecular oxidoreductases (5.3)
- C12Y503/01—Intramolecular oxidoreductases (5.3) interconverting aldoses and ketoses (5.3.1)
- C12Y503/01006—Ribose-5-phosphate isomerase (5.3.1.6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y503/00—Intramolecular oxidoreductases (5.3)
- C12Y503/01—Intramolecular oxidoreductases (5.3) interconverting aldoses and ketoses (5.3.1)
- C12Y503/01027—6-Phospho-3-hexuloisomerase (5.3.1.27)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/185—Escherichia
- C12R2001/19—Escherichia coli
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E50/00—Technologies for the production of fuel of non-fossil origin
- Y02E50/10—Biofuels, e.g. bio-diesel
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The invention provides a method for producing D-psicose by fermentation of escherichia coli by using methanol and D-xyloseThe enterobacter is used as a host cell, and a path from methanol and D-xylose to synthesis of D-psicose is established by expressing exogenous genes of methanol dehydrogenase Mdh, 3-hexose-6-phosphate synthase Hps, 6-phospho-3-hexose isomerase Phi, D-psicose-6-phosphate epimerase AlsE and D-psicose-6-phosphate phosphatase A6PP in wild escherichia coli. The protein tag SUMO is introduced to improve the expression quantity of the AlsE protein. By knocking out byproduct pathway genesfrmABRKey genes of the pentose phosphate pathwayrpiAAnd key genes of glycolytic pathwaypfkA,pfkBThe recombinant strain is obtained to realize rational control of a carbon source, so that the Escherichia coli can efficiently synthesize D-psicose by using methanol and D-xylose.
Description
Technical Field
The invention belongs to the field of metabolic engineering, and particularly relates to a method for producing D-psicose by fermenting escherichia coli by using methanol and D-xylose.
Background
D-psicose (D-Allulose), which is the C-3 epimer of D-fructose, is a rare zero-energy sugar, and has a sweet taste of 70% of that of sucrose. A large number of researches prove that the D-psicose has unique physicochemical properties and physiological functions, such as the effects of reducing blood fat and blood sugar, resisting inflammation, protecting nerves, eliminating the activity of Reactive Oxygen Species (ROS), treating atherosclerosis and the like, so the D-psicose has good market potential as an ideal sweetening agent and sucrose substitute, especially in the health care product and food industry.
D-psicose is a naturally occurring rare monosaccharide that is present in very small amounts in nature. The preparation method comprises a chemical synthesis method and a biological synthesis method. The chemical synthesis method comprises a selective aldol condensation synthesis method, a catalytic hydrogenation method, an addition reaction method, a Ferrier rearrangement method and the like. The chemical synthesis method has the problems of poor economy, serious environmental pollution, insufficient stereoselectivity and the like, and thus cannot be a mainstream method for preparing D-psicose. Compared with a chemical method, the biological enzyme catalysis method has the advantages of mild reaction conditions, high activity, low dosage, no toxicity, environmental friendliness and the like. However, the enzyme catalysis still has the problems of high production cost, long construction period, poor thermal stability and the like. In contrast, the microbial fermentation method is not only favorable for reducing the industrial production cost, but also conforms to the current green and environment-friendly production principle, and indicates the direction for synthesizing the D-psicose. Escherichia coli is transformed by a genetic engineering technology, so that the Escherichia coli can efficiently utilize methanol and D-xylose to synthesize D-psicose, and the yield of the D-psicose is greatly improved.
Disclosure of Invention
The invention aims to solve the problems and provides a method for producing D-psicose by fermenting Escherichia coli by using methanol and D-xylose. By expressing foreign genesmdh,hps,phi,alsE,a6PPObtaining the recombinant escherichia coli capable of preparing the D-psicose by using the methanol and the D-xylose as carbon sources, and knocking out a byproduct pathway genefrmABR, rpiA, pfkA,pfkBFinally, the recombinant strain for producing the D-psicose by using the methanol and the D-xylose is obtained, so that the high-efficiency utilization of the carbon source is realized, and the yield of the D-psicose is improved.
In order to achieve the purpose, the technical scheme of the invention is as follows:
d-psicose was produced using methanol and D-xylose in the metabolically engineered strain Escherichia coli JM109 (DE 3). Firstly, firstlyE.coliMethanol dehydrogenase gene required for expression in JM109 (DE 3)mdh3-hexose-6-phosphate synthase genehps6-phospho-3-hexose isomerase genephiD-psicose-6-phosphate epimerase genealsED-psicose-6-phosphate phosphatase genea6PP. The protein tag SUMO is introduced to improve the expression quantity of the AlsE protein. Then, by-product pathway gene was knocked outfrmABRKey genes of the pentose phosphate pathwayrpiAAnd key genes of glycolytic pathwaypfkA,pfkBAnd rational control of a carbon source is realized, so that the D-psicose is efficiently produced.
Further, the method for producing D-psicose by fermenting Escherichia coli with methanol and D-xylose specifically comprises the following steps:
(1) In thatE. coliRequired for expressing a path in JM109 (DE 3)Methanol dehydrogenase genemdh3-hexose-6-phosphate synthase genehps6-phospho-3-hexose isomerase genephiD-psicose-6-phosphate epimerase genealsED-psicose-6-phosphate phosphatase genea6PP. Getting through a path for synthesizing D-psicose by escherichia coli by using methanol and D-xylose to obtain a recombinant strainE. coli (Mdh, Hps, Phi, AlsE, A6PP);
(2) Introducing protein tag SUMO, fusion expressing AlsE-SUMO protein, enhancing expression amount of AlsE protein in Escherichia coli, respectively expressing exogenous proteins AlsE and A6PP and exogenous proteins AlsE-SUMO and A6PP in wild type Escherichia coli to obtain recombinant strainE. coli(AlsE, A6 PP) and recombinant strainsE. coli(SUMO-AlsE, A6 PP). By using extracellular enzyme catalysis experiment, determining the effective action of adding SUMO label on the high-efficiency expression of AlsE protein in Escherichia coli, and expressing proteins Mdh, hps, phi, SUMO-AlsE and A6PP in Escherichia coli to obtain recombinant strainE. coli (Mdh, Hps, Phi, SUMO-AlsE, A6PP);
(3) Knocking out a byproduct pathway gene of methanol utilization by using a lambda Red homologous recombination method on the basis of the step (2)frmABR(Gene ID:944988、944991、944986)Obtaining a recombinant strainE. coli(Mdh, hps, phi, SUMO-AlsE, A6PP, delta FrmABR) and product fermentation verification, and further constructing recombinant strainsE. coli(Mdh,. DELTA.FrmABR) and recombinant strainsE. coli(Mdh) validation of the knockout Gene by fermentationfrmABRThe effect on methanol consumption;
(4) In a bacterial strainE. coli(Mdh, hps, phi, SUMO-AlsE, A6PP,. DELTA.FrmABR) generpiA(Gene ID:947407)Obtaining a recombinant strainE. coli(Mdh, hps, phi, SUMO-AlsE, A6PP,. DELTA.FrmABR,. DELTA.RpiA) and performing product fermentation validation;
(5) In a bacterial strainE. coli(Mdh, hps, phi, SUMO-AlsE, A6PP,. DELTA.FrmABR,. DELTA.RpiA) knock-out of glycolytic pathway genespfkA(Gene ID:948412 Obtaining a recombinant strainE. coli(Mdh, hps, phi, SUMO-AlsE, A6PP,. DELTA.FrmABR,. DELTA.RpiA,. DELTA.PfkA) and performing product fermentation validation;
(6) In bacterial strainsE. coliKnocking out glycolytic pathway gene based on (Mdh, hps, phi, SUMO-AlsE, A6PP,. DELTA.FrmABR,. DELTA.RpiA,. DELTA.PfkA)pfkB(Gene ID:946230),Obtaining the target strainE. coli(Mdh, hps, phi, SUMO-AlsE, A6PP,. DELTA.FrmABR,. DELTA.RpiA,. DELTA.PfkA,. DELTA.PfkB) and verified by fermentation.
Further, a key gene in the synthesis pathway of the product expressed in step (1). Wherein the genemdhFrom hookworm bacteria, geneshpsFrom Bacillus methanolicus, genephiFrom Methylococcus capsulatus, genesalsEFrom Escherichia coli, genea6PPFrom bacteroides fragilis. Sequence reference NCBI database, genesmdh、hps、phi、alsE、a6PPAre WP _013953014.1, WP _014707664, WP _064496767, S101520_02794 and BF9343_0892, respectively.
Furthermore, the protein tag SUMO in the step (2) is artificially synthesized, and forms a fusion protein SUMO-AlsE with the protein AlsE, so as to enhance the expression level of the protein AlsE.
Further, in step (3), the gene knockout step is carried out by the lambda-red homologous recombination methodfrmABRInhibiting methanol byproduct pathway, and knocking out gene for verificationfrmABRInfluence on methanol consumption in knocking out genesfrmABRExpression of foreign genes in Escherichia coli JM109 (DE 3) and wild Escherichia coli JM109 (DE 3)mdhObtaining a strainE. coli(Mdh,. DELTA.FrmABR) and strainsE. coli(Mdh), fermentation in LB medium supplemented with 240mM methanol to verify the effect of methanol consumption.
Further, the gene knockout sequence in the steps (4), (5), (6) and (7) is required to be in accordance withfrmABR、rpiA、pfkA、pfkBTo avoid metabolic pathway errors.
Compared with the prior art, the invention has the beneficial effects that:
in the invention, a recombinant strain is obtained by expressing an exogenous gene in wild escherichia coli, opening a way that the escherichia coli synthesizes D-psicose by using methanol and D-xylose, and knocking out a product way geneE. coli(Mdh, hps, phi, SUMO-AlsE, A6PP, delta FrmABR, delta RpiA, delta PfkA, delta PfkB), the strain can effectively utilize cheap methanol and D-xylose to produce D-psicose, the yield of the D-psicose is greatly improved, and finally the yield of the D-psicose reaches 23.92 mM.
Drawings
FIG. 1 is a diagram of a cell factory.
FIG. 2 shows the effect of AlsE protein expression optimization,
(A) The SDS-polyacrylamide gel electrophoresis method verifies that the fusion protein AlsE-SUMO increases the expression of the protein, the first lane is empty plasmid, the second lane is protein AlsE, the third lane is protein AlsE-A6PP, and the fourth lane is protein AlsE-SUMO-A6PP;
(B) The dephosphorylation effect of the protein AlsE and the fusion protein AlsE-SUMO is verified through extracellular enzyme catalysis;
(C) The extracellular enzyme catalytic reaction verifies the influence of the fusion protein AlsE-SUMO on the yield of D-psicose;
(D) And a mass spectrum of the product D-psicose.
FIG. 3 knock-out GenefrmABRThe effect on methanol consumption and product formation;
(A) Recombinant strainE. coli(Mdh, hps, phi, SUMO-AlsE, A6 PP) product fermentation profile;
(B) Recombinant strainE. coli(Mdh, hps, phi, SUMO-AlsE, A6PP,. DELTA.FrmABR) product fermentation profile;
(C) Recombinant strainE. coli(Mdh,. DELTA.FrmABR) and recombinant strainsE. coli(Mdh) verify the methanol consumption fermentation profile.
FIG. 4 is a fermentation diagram of the strain;
(A) Recombinant strainE. coli(Mdh, hps, phi, SUMO-AlsE, A6PP,. DELTA.FrmABR,. DELTA.RpiA) product fermentation profile;
(B) Recombinant strainE. coli(Mdh, hps, phi, SUMO-AlsE, A6PP,. DELTA.FrmABR,. DELTA.RpiA,. DELTA.PfkA) product fermentation profile;
(C) Recombinant strainE. coli(Mdh, hps, phi, SUMO-AlsE, A6PP,. DELTA.FrmABR,. DELTA.RpiA,. DELTA.PfkA,. DELTA.PfkB) product fermentation profile.
Detailed Description
In order to make the present invention more comprehensible, the technical solutions of the present invention are further described below with reference to specific embodiments, but the present invention is not limited thereto.
Example 1
Recombinant strainE. coli(AlsE, A6 PP), and recombinant strainsE. coli(SUMO-AlsE, A6 PP), in 37 ℃ containing 60 u g/mL Kanna resistant 30 u g/mL chloramphenicol resistant LB medium until OD600 reaches 0.8-1.0, adding 0.2 mM isopropyl-beta-D-thiogalactoside (IPTG) protein at 37 ℃ to over-express for 16 h,4 ℃ centrifugation method to collect cells, using 50 mM pH7.0 HEPES buffer with 0.1M sodium chloride added, washing cells twice. The cells were resuspended in the same buffer to a final cell concentration OD600 of 50. Taking a proper amount of cell suspension, and carrying out ultrasonic cell disruption in an ice water bath. Centrifuging, collecting supernatant for enzyme activity experiment, and storing the rest supernatant at-20 deg.C.
A molybdate reagent is prepared, the solvent is ultrapure water, the solutes are 15 mM ammonium molybdate and 100 mM anhydrous zinc acetate, and the pH is adjusted to 5.0 by concentrated hydrochloric acid. Formulation 10% ascorbic acid reagent was adjusted to pH 5.0 with 40% NaOH.
The enzyme-activated reaction system is 600 mu L, and contains 100 mM HEPES buffer solution with pH7.0 and 5 mM MgCl 2 The method comprises the steps of taking 10 mM fructose-6-phosphate as a substrate, adding a proper amount of crude enzyme liquid, carrying out enzyme activity reaction in a thermostatic water bath at 37 ℃, starting the reaction from the addition of the crude enzyme liquid, carrying out reaction for 25 min, immediately placing a centrifugal tube into an ice-water bath after the reaction is finished, stopping the reaction, adding 2 mL of molybdic acid reagent and 500 μ L of ascorbic acid reagent into 200 μ L of a sample, mixing uniformly, allowing the system to react fully for 15 min at 30 ℃, testing an absorption peak at a wavelength of 850 nm by using an ultraviolet spectrophotometer after the reaction is finished, and displaying that the dephosphorylation effect of the fusion protein SUMO-AlsE is 2-3 times that of the protein AlsE by using an experimental result. The remaining sample after completion of the enzymatic reaction was subjected to a 0.2 μm membrane filtration treatment, and the sample analysis was carried out by HPLC, and D-psicose was determined by using a chromatographic column Waters Sugar-Pak TM I (RID) with water as a mobile phase at a flow rate of 0.5 mL/min and a sample retention time of 20 min. The determination result shows that the yield of D-psicose after the addition of the tag protein SUMO is the yield of the tag-free egg4 times white.
Example 2
Verification of knockout genesfrmABRInfluence on methanol consumption and products
Methanol consumption verification, gene knockoutfrmABRExpression of foreign genes in Escherichia coli JM109 (DE 3) and wild Escherichia coli JM109 (DE 3)mdhObtaining a strainE. coli(Mdh,. DELTA.FrmABR) and strainsE. coli(Mdh), adding 250 mM methanol to 50 mL LB medium of the system, 60. Mu.g/mL Carna resistance, growing at 37 ℃ to OD600 of 0.4-0.6, adding 0.2 mM IPTG, sampling every 12 h during 60 h of culture period for cell concentration determination and measuring the concentration of methanol by HPLC. The methanol measurement conditions were an Aminex HPX-87H column (75X 300 mM RID) as a column chromatography and 0.5 mM H as a mobile phase 2 SO 4 The flow rate of the ultrapure water solution is 0.6 mL/min, and the sample retention time is 25 min. The experimental result shows that the gene is knocked outfrmABRThe methanol consumption of the strain was reduced by 30 mM.
Product yield verification, recombinant strainsE. coli(Mdh, hps, phi, SUMO-AlsE, A6PP,. DELTA.FrmABR) and recombinant strainsE. coli(Mdh, hps, phi, SUMO-AlsE, A6 PP) in LB medium supplemented with 70 Mm D-xylose, 160 mM methanol, 60. Mu.g/mL kanamycin resistance, 30. Mu.g/mL chloramphenicol resistance, at 37 ℃ until OD600 reaches 0.4-0.6, 0.2 mM IPTG was added, and samples were taken every 12 h during the incubation period of 60 h to determine the cell concentration and the fermentation broth was subjected to HPLC analysis. The analysis method of D-xylose and D-psicose is the same, and the result shows that the gene is knocked outfrmABRAfter that, the yield of D-psicose increased from 1.039 mM to 2.21 mM.
Example 3
There are various combinations of more than one of the knocked-out strains. The final D-psicose yield is shown in the following table, consistent with the expectation, the culture medium is LB culture medium, the substrate is 70 mMD-xylose, 160 mM methanol, the resistance is 60 mug/mL kanamycin resistance and 30 mug/mL chloramphenicol resistance, 0.2 mM IPTG is added when the OD600 of the cells reaches 0.4-0.6 during the initial fermentation, the culture time is 60 h, the culture temperature is 37 ℃, and the experimental result shows that the recombinant DNA is compared with the recombinant DNAStrain of bacillusE. coli(Mdh, hps, phi, SUMO-AlsE, A6 PP), recombinant strainsE. coliThe yield of D-psicose (Mdh, hps, phi, SUMO-AlsE, A6PP,. DELTA.FrmABR,. DELTA.RpiA,. DELTA.PfkA,. DELTA.PfkB) increased from 1.039 mM to 23.92 mM.
The above description is only a preferred embodiment of the present invention, and all the equivalent changes and modifications made according to the claims of the present invention should be covered by the present invention.
Claims (6)
1. A method for producing D-psicose by fermentation of Escherichia coli with methanol and D-xylose is characterized by introducing exogenous genemdh、hps、phi、alsE、a6PPEstablishing a synthetic path for preparing D-psicose by using methanol and D-xylose as carbon sources, and knocking out by-product pathway genesfrmABRKey genes of the pentose phosphate pathwayrpiAAnd key genes of glycolytic pathwaypfkA、pfkBFinally, the recombinant strain for efficiently synthesizing the D-psicose is obtained.
2. The method for producing D-psicose by fermentation of Escherichia coli using methanol and D-xylose according to claim 1, wherein: the method specifically comprises the following steps:
1) By constructing recombinant vector, expressing exogenous proteins Mdh, hps, phi, alsE, A6PP in wild type Escherichia coli JM109 (DE 3) to obtain recombinant strainE. coli(Mdh, hps, phi, alsE, A6 PP), establishing a cell factory for synthesizing D-psicose with methanol and D-xylose as carbon sources;
2) By utilizing the SUMO label, fusion expression AlsE-SUMO protein is performed, the expression quantity of the AlsE protein in escherichia coli is enhanced, exogenous proteins AlsE and A6PP and exogenous proteins AlsE-SUMO and A6PP are respectively expressed in wild escherichia coli, and the recombinant strain is obtainedE. coli(AlsE, A6 PP) and recombinant strainsE. coli(SUMO-AlsE, A6 PP); further with the aid of extracellular enzyme catalysis experimentsAdding an SUMO label to effectively express the AlsE protein in the escherichia coli;
3) Knock-out of byproduct pathway genesfrmABR(Gene ID:944988、944991、944986)Key genes of the pentose phosphate pathwayrpiA(Gene ID:947407)And key genes of glycolytic pathwaypfkA(Gene ID:948412),pfkB (Gene ID:946230)Obtaining a recombinant strainE. coli(Mdh, hps, phi, alsE, A6PP,. DELTA.FrmABR,. DELTA.RpiA,. DELTA.PfkA,. DELTA.PfkB), thereby achieving efficient synthesis of D-psicose.
3. The method for producing D-psicose by fermentation of E.coli with methanol and D-xylose according to claim 2, wherein the foreign gene expressed in E.coli JM109 (DE 3) in step (1)mdh、hps、phiWhereinmdhThe gene is from the hookworm bacteria, and the gene is from the hookworm bacteria,hpsthe gene is from the bacillus methanolicus,phithe gene is from Methylococcus capsulatus, the gene sequence is referred to NCBI database,mdh、hps、phiNCBI sequence numbers of the genes are WP _013953014.1, WP _014707664 and WP _064496767 respectively,alsEthe gene is from Escherichia coli K-12 strain,a6PPthe genes are from Bacteroides fragilis, the gene sequences are referenced to NCBI database,alsEanda6PPthe NCBI sequence numbers of the genes are S101520_02794 and BF9343_0892 respectively.
4. The method for producing D-psicose by fermentation of E.coli using methanol and D-xylose according to claim 2, wherein the AlsE protein in step (2) is fusion-expressed by SUMO tag in order to enhance the intracellular expression effect of AlsE protein, E.coli JM109 (DE 3) is cultured at 37 ℃ and induces the expression of AlsE-SUMO protein, centrifuged at 4 ℃, cells are suspended twice using HEPES buffer solution at pH7.0, then disrupted by sonication, centrifuged and the supernatant is taken, and the protein expression effect is analyzed by SDS-polyacrylamide gel electrophoresis.
5. The method for producing D-psicose by fermentation of E.coli with methanol and D-xylose according to claim 2, wherein the reaction system of the extracellular enzyme catalysis experiment in step (2) is 600. Mu.L, in which fructose-6-phosphate is 10 mM, magnesium chloride is 5 mM, HEPES buffer solution is 100 mM at pH7.0, and crude enzyme solution is 20. Mu.L, and the reaction conditions of the enzyme catalysis experiment are 37 ℃ for 25 min, and 400. Mu.L of the reaction solution is taken and analyzed by HPLC.
6. The method for producing D-psicose by fermentation of E.coli with methanol and D-xylose according to claim 2, wherein the gene knockout in step (3) is performed according tofrmABR、rpiA、pfkA、pfkBThe sequence of (2) is carried out, and the specific knockout method refers to a lambda-red homologous recombination method.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211129170.0A CN115466758A (en) | 2022-09-16 | 2022-09-16 | Method for producing D-psicose by fermenting escherichia coli with methanol and D-xylose |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211129170.0A CN115466758A (en) | 2022-09-16 | 2022-09-16 | Method for producing D-psicose by fermenting escherichia coli with methanol and D-xylose |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115466758A true CN115466758A (en) | 2022-12-13 |
Family
ID=84332731
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211129170.0A Pending CN115466758A (en) | 2022-09-16 | 2022-09-16 | Method for producing D-psicose by fermenting escherichia coli with methanol and D-xylose |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115466758A (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20110041910A (en) * | 2009-10-16 | 2011-04-22 | 경상대학교산학협력단 | A echerichia coli comprising a polynucleotide encoding psicose 3-epimerase and method of producing psicose using the same |
WO2019144944A1 (en) * | 2018-01-25 | 2019-08-01 | 中国科学院天津工业生物技术研究所 | Engineering strain for producing psicose and derivatives thereof, construction method therefor and application thereof |
CN112501224A (en) * | 2020-11-26 | 2021-03-16 | 北京化工大学 | Method for biosynthesizing D-allose by using D-glucose |
CN113801833A (en) * | 2021-09-08 | 2021-12-17 | 福州大学 | Recombinant bacterium single-cell factory for producing D-psicose and construction and application thereof |
-
2022
- 2022-09-16 CN CN202211129170.0A patent/CN115466758A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20110041910A (en) * | 2009-10-16 | 2011-04-22 | 경상대학교산학협력단 | A echerichia coli comprising a polynucleotide encoding psicose 3-epimerase and method of producing psicose using the same |
WO2019144944A1 (en) * | 2018-01-25 | 2019-08-01 | 中国科学院天津工业生物技术研究所 | Engineering strain for producing psicose and derivatives thereof, construction method therefor and application thereof |
CN111712570A (en) * | 2018-01-25 | 2020-09-25 | 中国科学院天津工业生物技术研究所 | Engineering strain for producing allulose and derivatives thereof, and construction method and application thereof |
CN112501224A (en) * | 2020-11-26 | 2021-03-16 | 北京化工大学 | Method for biosynthesizing D-allose by using D-glucose |
CN113801833A (en) * | 2021-09-08 | 2021-12-17 | 福州大学 | Recombinant bacterium single-cell factory for producing D-psicose and construction and application thereof |
Non-Patent Citations (1)
Title |
---|
朱星星;杨培周;杜明睿;吴芸;姜绍通;: "根癌农杆菌D-阿洛酮糖-3-差向异构酶基因克隆、结构预测及原核表达", 食品科学技术学报, no. 03, 20 December 2018 (2018-12-20) * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2018515118A (en) | Method for producing 2'-fucosyl lactose using Corynebacterium glutamicum | |
US9944965B2 (en) | Biosynthesis of oligosaccharides | |
Valdehuesa et al. | Everyone loves an underdog: metabolic engineering of the xylose oxidative pathway in recombinant microorganisms | |
CN109370975B (en) | Method for improving yield of L-arginine synthesized by corynebacterium crenatum | |
CN104762286B (en) | The sucrose isomerase enzyme mutant that a kind of heat endurance and catalytic efficiency improve | |
Dong et al. | Enhanced curdlan production with nitrogen feeding during polysaccharide synthesis by Rhizobium radiobacter | |
US10233439B2 (en) | Directed modification of glucosamine synthase mutant and application thereof | |
EP4273224A1 (en) | Recombinant microorganism, preparation method therefor, and application of recombinant microorganism in production of tagatose | |
CN104388411A (en) | Agarase as well as gene and application thereof | |
CN105316310B (en) | A kind of alkaline pectin enzyme mutant of specific enzyme activity and thermal stability raising | |
CN108884120A (en) | For the novel method by using microorganism purifying 3,6- dehydration-L- galactolipin | |
CN112725319A (en) | Alginate lyase FaAly7 with polyG substrate specificity and application thereof | |
CN106995794B (en) | Succinic acid-producing actinobacillus engineering strain for improving succinic acid yield and construction method and application thereof | |
CN112708569B (en) | Yeast engineering bacterium for producing chondroitin sulfate by fermentation and application thereof | |
CN109628476B (en) | Method for producing 4-hydroxyisoleucine by using whole cell transformation | |
CN115466758A (en) | Method for producing D-psicose by fermenting escherichia coli with methanol and D-xylose | |
CN115074376B (en) | Method for efficiently synthesizing D-psicose by utilizing recombinant escherichia coli fermentation | |
CN109312314A (en) | New polyphosphate interdependence glucokinase and the method for preparing G-6-P using it | |
CN106119235A (en) | A kind of DPE deriving from bulkholderia cepasea and application thereof | |
CN111548978B (en) | Bacillus subtilis for producing mannan and application thereof | |
CN111607548B (en) | Recombinant escherichia coli for producing mannan and application thereof | |
CN102719463B (en) | A kind of method producing restructuring mixing L-arabinose isomerase | |
CN114250207B (en) | High-activity sucrose phosphorylase and application thereof | |
CN114395542B (en) | Sucrose phosphorylase and application thereof | |
CN106755022A (en) | Phosphoacetylglucosamine mutase AtAGM encoding genes and its enzyme, preparation, using with method for detecting enzymatic activity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |